A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery

Heart

Volumn 89, Issue 11, 2003, Pages 1327-1334

  Kertai, M D ^a   Boersma, E ^a   Bax, J J ^a   Heijenbrok Kal, M H ^a   Hunink, M G M ^a   L'Italien, G J ^b   Roelandt, J R T C ^a   Van Urk, H ^a   Poldermans, D ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; DOBUTAMINE;

AMBULATORY MONITORING; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ELECTROCARDIOGRAPHY; EXERCISE ELECTROCARDIOGRAPHY; HEART DEATH; HEART INFARCTION; HEART SCINTISCANNING; HUMAN; INTERMETHOD COMPARISON; MAJOR SURGERY; MEDLINE; META ANALYSIS; MODEL; NON INVASIVE MEASUREMENT; PERFORMANCE; PEROPERATIVE COMPLICATION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RADIOISOTOPE VENTRICULOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; VASCULAR SURGERY;

EID: 0041680951     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.89.11.1327     Document Type: Article

References (66)

1. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990;72:153-84.
2. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977;297:845-50.
3. Detsky AS, Abrams HB, McLaughlin JR, et al. Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med 1986;1:211-19.
4. L'Italien GJ, Paul SD, Hendel RC, et al. Development and validation of a Bayesian model for perioperative cardiac risk assessment in a cohort of 1081 vascular surgical candidates. J Am Coll Cardiol 1996;27:779-86.
5. Ouyang P, Gerstenblith G, Furman WR, et al. Frequency and significance of early postoperative silent myocardial ischemia in patients having peripheral vascular surgery. Am J Cardiol 1989;64:1113-16.
6. Raby KE, Goldman L, Creager MA, et al. Correlation between preoperative ischemia and major cardiac events after peripheral vascular surgery [see comments]. N Engl J Med 1989;321:1296-300.
7. Pasternack PF, Grossi EA, Baumann FG, et al. The value of silent myocardial ischemia monitoring in the prediction of perioperative myocardial infarction in patients undergoing peripheral vascular surgery. J Vasc Surg 1989;10:617-25.
8. Mangano DT, Browner WS, Hollenberg M, et al. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The study of perioperative ischemia research group. N Engl J Med 1990;323:1781-8.
9. Fleisher LA, Rosenbaum SH, Nelson AH, et al. The predictive value of preoperative silent ischemia for postoperative ischemic cardiac events in vascular and nonvascular surgery patients. Am Heart J 1991;122:980-6.
10. McPhail NV, Ruddy TD, Barber GG, et al. Cardiac risk stratification using dipyridamole myocardial perfusion imaging and ambulatory ECG monitoring prior to vascular surgery. Eur J Vasc Surg 1993;7:151-5.
11. Kirwin JD, Ascer E, Gennaro M, et al. Silent myocardial ischemia is not predictive of myocardial infarction in peripheral vascular surgery patients. Ann Vasc Surg 1993,7:27-32.
12. Fleisher LA, Rosenbaum SH, Nelson AH, et al. Preoperative dipyridamale thallium imaging and ambulatory electrocardiograpnic monitoring as a predictor of perioperative cardiac events and long-term outcome. Anesthesiology 1995;83:906-17.
13. Cutler BS, Wheeler HB, Paraskos JA, et al. Applicability and interpretation of electrocardiographic stress testing in patients with peripheral vascular disease. Am J Surg 1981;141:501-6.
14. Gardine RL, McBride K, Greenberg H, et al. The value of cardiac monitoring during peripheral arterial stress testing in the surgical management of peripheral vascular disease. J Cardiovasc Surg (Torino) 1985;26:258-61.
15. von Knorring J, Lepantalo M. Prediction of perioperative cardiac complications by electrocardiographic monitoring during treadmill exercise testing before peripheral vascular surgery. Surgery 1986;99:610-13.
16. Hanson P, Pease M, Berkoff H, et al. Arm exercise testing for coronary artery disease in patients with peripheral vascular disease. Clin Cardiol 1988;11:70-4.
17. Leppo J, Plaja J, Gionet M, et al. Noninvasive evaluation of cardiac risk before elective vascular surgery. J Am Coll Cardiol 1987;9:269-76.
18. Kaaja R, Sell H, Erkola O, et al. Predictive value of manual ECG-monitored exercise test before abdominal aortic or peripheral vascular surgery. Angiology 1993;44:11-15.
19. Urbinati S, Di Pasquale G, Andreoli A, et al. Preoperative noninvasive coronary risk stratification in candidates for carotid endarterectomy. Stroke 1994;25:2022-7.
20. Fiser WP, Thompson BW, Thompson AR, et al. Nuclear cardiac ejection fraction and cardiac index in abdominal aortic surgery. Surgery 1983;94:736-9.
21. Pasternack PF, Imparato AM, Bear G, et al. The value of radionuclide angiography as a predictor of perioperative myocardial infarction in patients undergoing abdominal aortic aneurysm resection. J Vasc Surg 1984;1:320-5.
22. Mosley JG, Clarke JM, Ell PJ, et al. Assessment of myocardial function before aortic surgery by radionuclide angiocardiography. Br J Surg 1985;72:886-7.
23. Pasternack PF, Imparato AM, Riles TS, et al. The value of the radionuclide angiogram in the prediction of perioperative myocardial infarction in patients undergoing lower extremity revascularization procedures. Circulation 1985,72:II13-17.
24. Kazmers A, Cerqueira MD, Zierler RE. The role of preoperative radionuclide left ventricular ejection fraction for risk assessment in carotid surgery. Arch Surg 1988;123:416-9.
25. Franco CD, Goldsmith J, Veith FJ, et al. Resting gated pool ejection fraction: a poor predictor of perioperative myocardial infarction in patients undergoing vascular surgery for infrainguinal bypass grafting. J Vasc Surg 1989;10:656-61.
26. McCann RL, Wolfe WG. Resection of abdominal aortic aneurysm in patients with low ejection fractions. J Vasc Surg 1989;10:240-4.
27. Fletcher JP, Antico VF, Gruenewald S, et al. Risk of aortic aneurysm surgery as assessed by preoperative gated heart pool scan. Br J Surg 1989;76:26-8.
28. Boucher CA, Brewster DC, Darling RC, et al. Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. N Engl J Med 1985;312:389-94.
29. Cutler BS, Leppo JA. Dipyridamole thallium 201 scintigraphy to detect coronary artery disease before abdominal aortic surgery. J Vasc Surg 1987;5:91-100.
30. Fletcher JP, Antico VF, Gruenewald S, et al. Dipyridamole-thallium scan for screening of coronary artery disease prior to vascular surgery. J Cardiovasc Surg (Torino) 1988;29:666-9.
31. Sachs RN, Tellier P, Larmignat P, et al. Assessment by dipyridamole-thallium-201 myocardial scintigraphy of coronary risk before peripheral vascular surgery. Surgery 1988;103:584-7.
32. Lane SE, Lewis SM, Pippin JJ, et al. Predictive value of quantitative dipyridamole-thallium scintigraphy in assessing cardiovascular risk after vascular surgery in diabetes mellitus. Am J Cardiol 1989;64:1275-9.
33. Eagle KA, Coley CM, Newell JB, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989;110:859-66.
34. Younis LT, Aguirre F, Byers S, et al. Perioperative and long-term prognostic value of intravenous dipyridamole thallium scintigraphy in patients with peripheral vascular disease. Am Heart J 1990;119:1287-92.
35. McEnroe CS, O'Donnell TFJ, Yeager A, et al. Comparison of ejection fraction and Goldman risk factor analysis to dipyridamole-thallium 201 studies in the evaluation of cardiac morbidity after aortic aneurysm surgery. J Vasc Surg 1990;11:497-504.
36. Strawn DJ, Guernsey JM. Dipyridamole thallium scanning in the evaluation of coronary artery disease in elective abdominal aortic surgery. Arch Surg 1991;126:880-4.
37. Watters TA, Botvinick EH, Dae MW, et al. Comparison of the findings on preoperative dipyridamole perfusion scintigraphy and intraoperative transesophageal echocardiography: implications regarding the identification of myocardium at ischemic risk. J Am Coll Cardiol 1991;18:93-100.
38. Mangano DT, London MJ, Tubau JF, et al. Dipyridamole thallium-201 scintigraphy as a preoperative screening test. A reexamination of its predictive potential. Study of Perioperative Ischemia Research Group. Circulation 1991;84:493-502.
39. Hendel RC, Whitfield SS, Villegas BJ, et al. Prediction of late cardiac events by dipyridamole thallium imaging in patients undergoing elective vascular surgery. Am J Cardiol 1992;70:1243-9.
40. Madsen PV, Vissing M, Munck O, et al. A comparison of dipyridamole thallium 201 scintigraphy and clinical examination in the determination of cardiac risk before arterial reconstruction. Angiology 1992;43:306-11.
41. Bry JD, Belkin M, O'Donnell TFJ, et al. An assessment of the positive predictive value and cost-effectiveness of dipyridamole myocardial scintigraphy in patients undergoing vascular surgery. J Vasc Surg 1994;19:112-21.
42. Baron JF, Mundler O, Bertrand M, et al. Dipyridamole-thallium scintigraphy and gated radionuclide angiography to assess cardiac risk before abdominal aortic surgery. N Engl J Med 1994;330:663-9.
43. Ombrellaro MP, Dieter RA, Freeman M, et al. Role of dipyridamole myocardial scintigraphy in carotid artery surgery. J Am Coll Surg 1995;181:451-8.
44. Erickson CA, Carballo RE, Freischlag JA, et al. Using dipyridamole-thallium imaging to reduce cardiac risk in aortic reconstruction. J Surg Res 1996;60:422-8.
45. Vanzetto G, Machecourt J, Blendea D, et al. Additive value of thallium single-photon emission computed tomography myocardial imaging for prediction of perioperative events in clinically selected high cardiac risk patients having abdominal aortic surgery. Am J Cardiol 1996;77:143-8.
46. Klonaris CN, Bastounis EA, Xiromeritis NC, et al. The predictive value of dipyridamole-thallium scintigraphy for cardiac risk assessment before major vascular surgery. Int Angiol 1998;17:171-8.
47. Huang Z, Komori S, Sawanobori T, et al. Dipyridamole thallium-201 single-photon emission computed tomography for prediction of perioperative cardiac events in patients with arteriosclerosis obliterans undergoing vascular surgery. Jpn Circ J 1998;62:274-8.
48. de Virgilio C, Kirby L, Lewis RJ, et al. Limited utility of dipyridamole-thallium for predicting adverse cardiac events after vascular surgery. Vasc Surg 1998;32:275-9.
49. de Virgilio C, Toosie K, Elbassir M, et al. Dipyridamole-thallium/ sestamibi before vascular surgery: a prospective blinded study in moderate-risk patients. J Vasc Surg 2000;32:77-89.
50. Tischler MD, Lee TH, Hirsch AT, et al. Prediction of major cardiac events after peripheral vascular surgery using dipyridamole echocardiography. Am J Cardiol 1991;68:593-7.
51. Pasquet A, D'Hondt AM, Verhelst R, et al. Comparison of dipyridamole stress echocardiography and perfusion scintigraphy for cardiac risk stratification in vascular surgery patients. Am J Cardiol 1998;82:1468-74.
52. Rossi E, Citterio F, Vescio MF, et al. Risk stratification of patients undergoing peripheral vascular revascularization by combined resting and dipyridamole echocardiography. Am J Cardiol 1998;82:306-10.
53. Sicari R, Ripoli A, Picano E, et al. Perioperative prognostic value of dipyridamole echocardiography in vascular surgery: a large-scale multicenter study in 509 patients. EPIC (Echo Persantine International Cooperative) Study Group. Circulation 1999;100:II269-74.
54. Lalka SG, Sawada SG, Dalsing MC, et al. Dobutamine stress echocardiography as a predictor of cardiac events associated with aortic surgery. J Vasc Surg 1992;15:831-40.
55. Davila-Roman VG, Waggoner AD, Sicard GA, et al. Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular disease. J Am Coll Cardiol 1993;21:957-63.
56. Langan EM, Youkey JR, Franklin DP, et al. Dobutamine stress echocardiography for cardiac risk assessment before aortic surgery. J Vasc Surg 1993;18:905-11.
57. Poldermans D, Fioretti PM, Forster T, et al. Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation 1993;87:1506-12.
58. Eichelberger JP, Schwarz KQ, Black ER, et al. Predictive value of dobutamine echocardiography just before noncardiac vascular surgery. Am J Cardiol 1993;72:602-7.
59. Poldermans D, Arnese M, Fioretti PM, et al. Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography. J Am Coll Cardiol 1995;26:648-53.
60. Shafritz R, Ciocca RG, Gosin JS, et al. The utility of dobutamine echocardiography in preoperative evaluation for elective aortic surgery. Am J Surg 1997;174:121-5.
61. Boersma E, Poldermans D, Bax JJ, et al. The combination of clinical characteristics, dobutamine echocardiography and beta-blocker use optimizes perioperative management of patients scheduled for major vascular surgery. JAMA 2001;285:1865-73.
62. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986;7:177-88.
63. Rose EL, Liu XJ, Henley M, et al. Prognostic value of noninvasive cardiac tests in the assessment of patients with peripheral vascular disease. Am J Cardiol 1993;71:40-4.
64. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to update the 1996 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). J Am Coll Cardiol 2002;39:542-53.
65. Poldermans D, Bax JJ, Thomson IR, et al. Role of dobutamine stress echocardiography for preoperative cardiac risk assessment before major vascular surgery: a diagnostic tool comes of age. Echocardiography 2000;17:79-91.
66. Poldermans D, Rambaldi R, Bax JJ, et al. Safety and utility of atropine addition during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. Eur Heart J 1998;19:1712-18.